Theranos was a privately held American health technology company founded in 2003 by Stanford University dropout Elizabeth Holmes. It promised to transform blood testing with analyzers that could run a broad panel of diagnostic tests on a few drops of blood. The company's technology did not work as claimed, and its collapse after 2015 became one of the best-known corporate fraud cases in Silicon Valley history. Holmes and her business partner were both convicted of investor fraud.
Origins and business model
The company's name combined "therapy" and "diagnosis". Holmes first called the venture Real-Time Cures and later renamed it Theranos. She dropped out of Stanford in 2003 with the aim of making blood tests easy and affordable.
The central pitch was that patients would no longer need to give several tubes of blood. Just a few drops would be enough to look for markers of cholesterol, diabetes, cancer and other conditions. Samples were to be collected with a specially designed fingerstick device and analyzed in the company's own machines. The main analyzer went under several names, including the Theranos Sample Processing Unit, "Edison" and "minilab". Holmes asserted that the proprietary analyzer could run any test that conventional labs ran, from a fingerstick sample rather than a vein draw.
Theranos raised large sums of private capital from prominent backers. Sources differ on the totals: one reports more than $945 million raised from investors including Rupert Murdoch, the Walton family, and the DeVos family, while another puts investment at more than USD 400 million. Its valuation peaked at about $9 billion in 2014, which made Holmes the youngest self-made female billionaire in the country by one count. In 2014 she was on the Forbes list of the richest Americans and was named the world's youngest self-made woman billionaire.
Technical failures and exposure
Doubts about the technology surfaced in 2015. Through whistleblower accounts and the research of a Wall Street Journal reporter, it emerged that more than 200 advertised tests could not be performed on the Edison machine, and the results from the few it could run were unreliable. The reporting by investigative journalist John Carreyrou in the Wall Street Journal in October 2015 was central to this. It reported that Theranos was not using its own machines for most blood tests and that the Edison device produced unreliable results. Theranos denied these allegations.
Regulators then became involved. In January 2016, after unreliable results in detecting a blood thinner, the federal regulator CMS warned that Theranos tests endangered patient health. CMS proposed banning Holmes, along with company president Sunny Balwani, from the blood-testing business for at least two years over the company's failure to fix major problems at its California laboratory.
In May 2016 the company disclosed that it had voided its Edison results. All results from Edison devices in 2014 and 2015 were discarded and updated reports were sent to doctors. Theranos also said it had issued tens of thousands of corrected reports to doctors and patients. The correction affected patients in multiple states, and some doctors acted on results that were later withdrawn. Physicians near Phoenix, Arizona said they had received corrected reports, and one sent a patient to the emergency room based on erroneous results.
Commercial partners withdrew. Walgreens ended its partnership with Theranos, citing the voided test results and the CMS rejection of the company's plan of correction.
Legal proceedings
Federal and state authorities opened investigations into whether the company had misled investors. In early 2018 the SEC brought charges against Holmes and Balwani. In June 2018 California authorities also filed charges against both. The company was wound down soon after. By 2018, Holmes stepped down as CEO, and the company officially ceased operations.
Holmes was tried in 2021. She was convicted in January 2022 on four counts of lying to investors about the company's technology and its financial health. Jurors did not convict her on all charges. Balwani was tried separately and was sentenced in December 2022 to nearly 13 years in prison. Holmes received a sentence of 11 years and 3 months in federal prison.
Sentence and recent developments
Holmes entered federal custody in May 2023 and was held at a minimum-security camp in Bryan, Texas. Her sentence was later reduced. A federal judge reduced it in March 2026 under a retroactive change to federal sentencing guidelines. Reporting on the length of the reduced term varies. One source gives a 10-year, three-month sentence, while another describes it as 123 months, or 10 years and three months.
In September 2026 the Bureau of Prisons informed victims that Holmes would be moved to a residential halfway house. The transfer is scheduled for August 23, 2027, to the BOP Austin Transitional Center in Del Valle, Texas. Her projected full release date remains February 22, 2030. Holmes has also asked for presidential clemency, and the Justice Department lists the application as pending. The White House had not commented on the request at the time of reporting.
Significance
Theranos is often cited in discussions of ethics in startups and of information asymmetry between founders and investors. Critics point to a culture of secrecy inside the company, in which engineers were siloed so that no single team could see the full picture. The case also raised questions for medicine and regulation: laboratory-developed tests reached patients before the company's claims were checked. Patients were harmed by inaccurate results, including false positives for HIV and cancer reported in later accounts.
The episode has been the subject of books, a television series, and documentary films, which have helped keep it in public discussion.
References
- Theranos - Most audacious scams in startup historymilliondollarminds.substack.com
- Theranosebsco.com
- Elizabeth Holmes and the Theranos Case: History of a Fraud Scandalintegrityline.com
- Northern District of Californiajustice.gov
- Why Theranos Failed — The blood-testing startup built on a lieplanmysaas.com
- Elizabeth Holmes and the Theranos Scandal Explainedbritannica.com
- theranos void edison resultsdc.fortune.com
- Theranos reportedly voids two years of results from its Edison blood-testing devicestechcrunch.com
- Walgreens ends relationship with Theranos in latest blow for start-up founder Elizabeth Holmescnbc.com
- What Was the Theranos Scandal? The Full Story - ScienceInsightsscienceinsights.org
- elizabeth holmes sentenced theranos trial rcna57344nbcnews.com
- elizabeth holmes prison release date rcna149825nbcnews.com
- How long is Elizabeth Holmes’s prison sentence?britannica.com
- Elizabeth Holmes Prison: Latest Sentence, Release Date and Clemency Statuslegalunitedstates.com
- Elizabeth Holmes to Be Released From Prison and Sent to Halfway House Next Yearthewrap.com
- Elizabeth Holmes Is Leaving Prison Early—What We Knowforbes.com
- Trial of Elizabeth Holmesen.wikipedia.org
- Theranos, Inc.britannica.com
- Elizabeth Holmesbritannica.com